Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Predictors of subsequent CRE infection after colonization in multivariable analysis

From: Development of a risk prediction model for subsequent infection after colonization with carbapenem-resistant Enterobacterales: a retrospective cohort study

Variable

Subhazard ratio (95% CI)

P-value

Multisite colonization

1.39 (1.02–1.91)

0.04

Polymicrobial colonization

1.80 (1.21–2.67)

0.004

Catheterization after CRE colonization

1.69 (1.22–2.34)

0.002

Concomitant respiratory diseases

2.23 (1.56–3.17)

< 0.001

Receiving carbapenems before CRE colonization within 90 days

1.61 (1.10–2.34)

0.014

Receiving antimicrobial combination therapy before CRE colonization with 90 days

1.99 (1.28–3.11)

0.002

Receiving albumin after CRE colonization

0.65 (0.49–0.88)

0.005

  1. Abbreviations CI: Confidence Interval, CRE: carbapenem-resistant Enterobacterales